Description of Collaborative Activity: |
Description of Collaborative Activity: On September 18, 2014, the President issued Executive Order 13676 on Combating Antibiotic-Resistant Bacteria and the and the Antimicrobial Resistance Challenge was called for in the accompanying White House Fact Sheet. The development and use of rapid, point-of-care, and innovative diagnostic tests for identification and characterization of resistant bacteria was a goal identified in the National Strategy for Combating Antibiotic-Resistant Bacteria released in September 2014 and addressed in the National Action Plan for combating Antibiotic-Resistant Bacteria released in March 2015. In conformance with the previous documents, the NIH and BARDA are sponsoring a prize competition, and the FDA and CDC are contributing technical and regulatory expertise to develop the award evaluation process. The aim of the prize competition is to incentivize the development of one or more in vitro diagnostic tests that would be of significant clinical and public health utility to combat the development and spread of antibiotic resistant bacteria. The AMR Challenge Working Group meets bi-weekly. |
NIH Participating Institutes/Centers/Office of the Director: |
NIAID, OD/DPCPSI, OD/OIR/OTT, OD/OLPA, OD/OSP |
